GleamWall
中文EN

BLCO Bausch & Lomb Corp

Ophthalmic Goods · NYSE · SEC CIK 1860742 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY8.9%
TTM net income YoY63.6%
TTM EPS YoY62.8%
Revenue 3-yr CAGR10.9%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin7.1%
Net margin-2.0%
FCF margin4.7%
EBITDA margin14.5%

Returns

ROE-1.7%
ROA-0.8%
ROIC (approx.)2.8%
Asset turnover0.39x

Leverage & solvency

Liabilities / assets53.4%
Debt / equity0.78x
Current ratio1.56x
Interest coverage1.00x

Cash quality & payout

Operating cash flow / net income-4.99x
Accruals ratio-4.8%
Payout ratio—
Capex / revenue5.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$1.38B$1.39B$1.24B$1.41B$1.28B$1.28B$1.14B$1.28B
R&D expense$91.00M$114.00M$101.00M$94.00M$95.00M$96.00M$86.00M$93.00M
SG&A expense$556.00M$588.00M$544.00M$564.00M$528.00M$579.00M$563.00M$532.00M
Operating income$155.00M$83.00M$33.00M$112.00M$95.00M-$11.00M-$83.00M$87.00M
Interest expense$95.00M$93.00M$97.00M$98.00M$101.00M$128.00M$94.00M$98.00M
Pretax income$58.00M-$11.00M-$64.00M$13.00M-$3.00M-$147.00M-$180.00M-$10.00M
Income tax$23.00M-$1.00M$6.00M$71.00M$22.00M-$89.00M$31.00M-$8.00M
Net income$32.00M-$14.00M-$71.00M-$58.00M-$28.00M-$62.00M-$212.00M-$3.00M
EBITDA$257.00M$185.00M$134.00M$211.00M$204.00M$96.00M$23.00M$193.00M
EPS (basic)0.09-0.04-0.20—-0.08-0.18-0.60—
EPS (diluted)0.09-0.04-0.20—-0.08-0.18-0.60—
Weighted avg. shares (diluted)361.50M357.10M355.20M—354.20M353.70M352.80M—
Balance sheet
Cash & equivalents$513.00M$367.00M$268.00M$383.00M$332.00M$272.00M$215.00M$316.00M
Receivables$1.15B$1.16B$1.11B$1.22B$1.09B$1.08B$1.01B$1.03B
Inventory$1.01B$999.00M$977.00M$976.00M$1.00B$1.05B$1.03B$1.04B
Current assets$3.06B$2.92B$2.78B$2.98B$2.85B$2.85B$2.69B$2.79B
PP&E, net$1.81B$1.80B$1.79B$1.76B$1.71B$1.68B$1.58B$1.49B
Goodwill$4.71B$4.72B$4.74B$4.76B$4.66B$4.67B$4.57B$4.52B
Intangibles$3.13B$3.17B$3.23B$3.28B$3.33B$3.36B$3.43B$3.49B
Total assets$13.96B$13.86B$13.78B$14.02B$13.83B$13.83B$13.43B$13.47B
Current liabilities$1.96B$1.89B$1.82B$1.92B$1.90B$1.84B$1.73B$1.74B
Short-term debt$28.00M$28.00M$28.00M$28.00M$28.00M$28.00M$40.00M$40.00M
Long-term debt$4.99B$5.05B$5.01B$5.02B$4.92B$4.93B$4.79B$4.74B
Total debt$5.02B$5.08B$5.04B$5.05B$4.95B$4.96B$4.83B$4.78B
Total liabilities$7.45B$7.42B$7.33B$7.50B$7.33B$7.32B$7.00B$6.92B
Shareholders' equity$6.44B$6.38B$6.38B$6.45B$6.43B$6.44B$6.36B$6.47B
Net debt$4.50B$4.71B$4.77B$4.67B$4.62B$4.69B$4.61B$4.47B
Shares outstanding357.39M357.06M356.40M354.21M354.09M353.80M353.36M352.40M
Cash flow statement
Operating cash flow$233.00M$153.00M$32.00M$136.00M$137.00M$35.00M-$25.00M$22.00M
Capital expenditure$55.00M$71.00M$100.00M$76.00M$74.00M$89.00M$110.00M$92.00M
Free cash flow$178.00M$82.00M-$68.00M$60.00M$63.00M-$54.00M-$135.00M-$70.00M
Investing cash flow-$73.00M-$87.00M-$130.00M-$188.00M-$61.00M-$90.00M-$116.00M-$185.00M
Financing cash flow-$22.00M$34.00M-$20.00M$116.00M-$12.00M$90.00M$31.00M$146.00M
Depreciation & amortization$102.00M$102.00M$101.00M$99.00M$109.00M$107.00M$106.00M$106.00M
Stock-based compensation$37.00M$38.00M$34.00M$64.00M$27.00M$30.00M$28.00M$27.00M

Free plan shows the latest 8 periods; Pro shows all 23 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.